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Differentiation of CD34+ stem/progenitor cells into megakaryocytes is thought to be a uniform, unidirectional process, in which cells
transform step by step from less differentiated precursor stages to more differentiated megakaryocytes. Here we propose the concept and
present evidence based on single-cell analysis that differentiation occurs along multiple, partially asynchronous routes. In all CD34+ cells
cultured with thrombopoietin, surface appearance of glycoprotein IIIa (GPIIIa) preceded that of GPIb, indicating that the expression of these
glycoproteins occurs in a timely ordered manner. Cellular F-actin content increased in parallel with GPIb expression. Only cells that
expressed GPIb were polyploid, pointing to co-regulation of GPIb expression, actin cytoskeleton formation and polyploidization during
megakaryocytopoiesis. On the other hand, most progenitor cells responded to thrombin but not to thromboxane A2 analogue by rises in
cytosolic [Ca2 +]i. The appearance of thromboxane-induced responses during megakaryocytopoiesis was not strictly linked to glycoprotein
expression, because cells showed responsiveness either before or after GPIb expression. The same non-strictly sequential pattern was
observed for disappearance of the Ca2 + response by prostacyclin mimetic; in some megakaryocytes it occurred before and in others after
GPIb expression. Thus, megakaryocytic differentiation follows along independent routes that are either strictly sequential (GPIIIa and GPIb
expression) or proceed at different velocities (Ca2 + signal regulation).
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1. Introduction egakaryocyte, granular megakaryocyte and mature mega-The growth factor thrombopoietin regulates the differen-
tiation of CD34+ hematopoietic stem/progenitor cells into
mature platelet-producing megakaryocytes [1–3]. The gen-
eral concept is that this differentiation process proceeds in a
uniform, unidirectional way, in which the progenitor cells,
step by step, pass the stages of high-proliferative potential
cell-megakaryocyte, burst forming unit-megakaryocyte, col-
ony forming unit-megakaryocyte, promegakaryoblast, prom-0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2003.09.004
Abbreviations: BSA, bovine serum albumin; FITC, fluorescein
isothiocyanate; GP, glycoprotein; PBS, phosphate-buffered saline; PE,
phycoerythrin; vWF, von Willebrand factor
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(J.W.M. Heemskerk).karyocyte [4–6]. Because the cells differentiate asynchro-
nously, it is evident that populations of differentiating he-
matopoietic stem/progenitor cells will show a continuum
encompassing the maturation stages. This simple view of the
differentiation process tacitly assumes that every cell passes
the same set of differentiation landmarks during its route to
become a mature megakaryocyte, ready to shed platelets.
The major structural features of megakaryocytic differ-
entiation are an increase in nuclear size with DNA poly-
ploidization and an increase in cytoplasmic volume with
formation of secretory granules and demarcation mem-
branes [7–9]. Cytoplasmic fragments are then released
and form proplatelets. These structural changes are accom-
panied by progressive expression of adhesive glycoprotein
complexes implicated in platelet function. Human CD34+
progenitor stem cells cultured with thrombopoietin and
additional cytokines thus transcribe and express the fibrin-
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CD61, integrin aIIbh3), and the von Willebrand factor
(vWF) receptor, glycoprotein Ib–IX–V (CD42a–d com-
plex), on their cell surface during megakaryocytopoiesis
[7,10,11]. We have shown earlier that these membrane
changes go hand in hand with typical changes in signal
transduction machinery indispensable for platelet activation:
for instance, considerable up-regulation of the GTP-binding
proteins, Gia2 and Gqa, and of specific members of the Trp
family of Ca2 + influx channels [11,12]. These protein
changes are accompanied by increases in Ca2 + mobilization
and Ca2 + influx by the Gq-coupled receptor agonists,
thrombin and thromboxane A2. At the same time, there is
a decrease in Ca2 + signaling by the cAMP-elevating agent
prostacyclin, which becomes a potent inhibitor of activation
of matured platelets [13]. On a molecular level, this signal-
ing change is accompanied by the appearance of cAMP-
dependent protein kinase regulatory subunit IIh [14].
In the present study, we used single-cell techniques to
compare the expression of surface glycoproteins and signal
transducing properties of CD34+ stem/progenitor cells dur-
ing their progressive differentiation to megakaryocytes. We
show that the changes in glycoprotein expression are strictly
sequential but, surprisingly, occur essentially independent of
the appearance of maturation-linked signaling events.2. Materials and methods
2.1. Materials
Human a-thrombin, U46619 and bovine serum albumin
(BSA) were from Sigma (St. Louis, MO, USA). Platelet-
activating factor was from Boehringer (Mannheim, Ger-
many). The prostacyclin analogue iloprost was a gift from
Schering (Berlin, Germany). Immuno-magnetic hematopoi-
etic progenitor cell isolation kit (mini-MACS) for the
isolation of CD34+ cells (using QBEND/10 anti-CD34)
was from Miltenyi Biotec (Bergisch Gladbach, Germany).
Fura-2 acetoxymethyl ester and Texas red-X phalloidin were
from Molecular Probes (Leiden, The Netherlands).
Monoclonal anti-GPIIIa (anti-CD61, 7F12) and mono-
clonal anti-GPIb (anti-CD42b, 6.20) were kindly provided
by Dr. H.K. Nieuwenhuis, Department of Haematology
(University Medical Center Utrecht, The Netherlands).
Fluorescein isothiocyanate (FITC)-conjugated antibodies
against GPIb (F802) and GPIIIa (F803), phycoerythrin
(PE)-conjugated anti-GPIba (R7014) and anti-GPIIb
(R7058) antibodies, FITC- and PE-labeled negative control
antibody (X949), and FITC-conjugated rabbit anti-mouse
IgG were all from Dako (Glostrup, Denmark). FITC-labeled
anti-CD34 antibody (HPCA-2), which reacts with a differ-
ent epitope than the QBEND/10 anti-CD34 antibody used in
the immuno-magnetic isolation, was purchased from Becton
Dickinson (Mountain View, CA, USA). Other chemicals
came from sources described elsewhere [12].2.2. Isolation of CD34+ progenitor cells from umbilical
cord blood
Umbilical cord blood was collected during normal full-
term deliveries and used within 48 h. Written informed
consent was obtained from all mothers before labour and
delivery. Typically, 100–160 106 low-density mononucle-
ar blood cells, in a volume of 40 ml, were isolated from
umbilical cord blood obtained from one donor after centri-
fugation of the blood on a layer of Ficoll Paque. Using the
mini-MACS immuno-magnetic system, about 0.4 106
CD34+ stem/progenitor cells were isolated from the mono-
nuclear cell population. At the start of culture (day 2), the
purity of the isolated cell population, determined by flow
cytometry after incubation with FITC-labelled anti-CD34
(HPCA-2), was 96F 2% (meanF S.D., n = 5). The remain-
ing cells mostly consisted of CD15+ cells (monocytes) and
occasional erythrocytes. Note that CD14 (on monocytes)
was not detected in the population, neither was CD19 (B
lymphocytes) nor CD61 (GPIIIa or h3 chain of integrin
aIIbh3).
2.3. Cell culture and flow cytometric analysis
Isolated stem/progenitor cells were cultured in a six-well
plate in culture medium consisting of IMDM supplemented
with 10% (v/v) human AB plasma, 2 mM L-glutamine, 100
U/ml penicillin and 100 U/ml streptomycin. Cell concentra-
tion at the start was 4 105/ml. Human AB plasma was
prepared from heparin-anticoagulated blood (10 U/ml),
obtained from healthy donors after informed consent.
Thrombopoietin was added to a final concentration of 20
ng/ml. Cells were cultured at 37 jC in a humidified
atmosphere with 5% CO2.
Expression of GPIIIa, and GPIb was determined by flow
cytometry. The cells were incubated with FITC-labeled anti-
GPIIIa, PE-labeled anti-GPIb or anti-GPIIb or FITC/PE-
labeled IgG (control) in phosphate-buffered saline (PBS) pH
7.4, supplemented with 1.0% (w/v) BSA, for 20 min at 4
jC. After washing, the cells were analysed on a FACScan
(Becton Dickinson). The nuclear DNA content (ploidy) of
the megakaryocytes was assessed by flow cytometry after
staining with propidium iodide in the presence of FITC-
labeled anti-GPIIIa or anti-GPIb, essentially as described by
Debili et al. [7].
2.4. F-actin staining
Cells on poly-L-lysine coated coverslips were fixed with
3.7% (v/v) formaldehyde in PBS, and subsequently per-
meabilised with 0.005% (w/v) sodium dodecylsulfate in
PBS. After blocking with BSA [5% (w/v), 30 min at room
temperature], Texas red-X phalloidin (0.5 AM) labeling was
performed to stain F-actin. Samples were visualised by
confocal laser scanning microscopy, using a Bio-Rad
MRC 600 system [15].
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single cells
For vital fluorescence microscopic imaging experiments,
day 1 stem/progenitor cells were adhered to a round glass
coverslip (22 mm in diameter), coated with a monoclonal
antibody against human CD34 (QBEND/10), and blocked
with BSA. Cells that were cultured with thrombopoietin for
5 or 10 days were adhered to an anti-GPIIIa (7F12)-coated
coverslip. Adhesion time was 30 min at 37 jC. Routinely,
50 Al of a suspension of 5 105 cells/ml was incubated per
10-mm2 coverslip. This procedure did not activate the cells,
as indicated by a low resting level of [Ca2 +]i and the
absence of stress fibers or membrane blebbing. FACS
analysis of the non-bound day-5 and day-10 cells, after
labeling with anti-GPIIIa–FITC, showed that this cell
population did not contain GPIIIa-positive cells. Essentially
all cells that bound to the 7F12-coated coverslip stained
positively with anti-GPIIIa–FITC. The adhered cells on the
coverslip were incubated with Fura-2 acetoxymethyl ester
(0.25 AM) in HEPES buffer pH 7.4, composed of 145 mM
NaCl, 10 mM HEPES, 5 mM KCl, 2 mM MgCl2, 1 mM
CaCl2, 0.1% (w/v) glucose and 0.1% (w/v) BSA, for 45 min
at room temperature. After loading, the cells were washed
and the coverslip was positioned in a preheated chamber (37
jC) on an inverted microscope (Nikon Diaphot 200, Tokyo,
Japan). Changes in Fura-2 fluorescence ratio in individual
cells were detected using a Quanticell 700 fluorometric
video imaging system equipped with excitation and emis-
sion filter wheels (Visitech, Sunderland, Tyne and Wear,
UK) as described [16]. Averaged, ratioed and background
subtracted fluorescence images were measured every 2–3 s.
Calibration parameters to determine [Ca2 +]i were derived as
described previously [17]. The cells were stimulated by
application of prewarmed HEPES buffer supplemented with
agonist. The criterion for counting a cell as Ca2 + responsive
was an agonist-induced increase in [Ca2 +]i that was three
times higher than the noise fluctuations in [Ca2 +]i after
calibration.
After recording the changes in [Ca2 +]i in each exper-
iment, the cells were incubated with FITC-labeled anti-
bodies for further characterization. As a minority of the
cells (5–10%) adhering to an anti-GPIIIa-coated coverslip
had monocytic characteristics, first staining was performed
with anti-CD14–FITC (PBS with 0.5% BSA, 5 min at 37
jC). All individual cells that stained positively for CD14
were excluded from analysis of the Ca2 + responses (0–
5% of total adhering cells). The CD14+ cells, regardless
of the culturing time with thrombopoietin, typically failed
to respond to thrombin. Subsequently, the cells were
incubated with anti-GPIb–FITC (PBS with 0.5% BSA,
5 min at 37 jC) to identify GPIb+ megakaryocytes.
Staining with anti-GPIIIa–FITC was performed when
appropriate. In control experiments, cells on coverslips
were incubated with FITC-labeled control IgG; no staining
was observed.
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Differences between groups were tested with Student’s
two-sample test. Correlations between various parameters
were tested with simple regression analysis (Pearson).
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3.1. Strictly sequential expression of GPIIIa and GPIb
during megakaryocytopoiesis
Human, hematopoietic CD34+ progenitor cells were
immuno-magnetically isolated from umbilical cord blood.
This resulted in a purified cell suspension containing
96F 2% CD34+ cells (meanF S.D., n= 5). Remaining cells
were mainly CD15+ monocytes with occasional erythro-
cytes (see Materials and methods). When culturing these
cells in the presence of thrombopoietin, cell number in-
creased by 4.5-fold at day 5, and 5.8-fold at day 10. The
average size of the cells in population increased little from
11F1.1 to 14F 1.5 Am (n = 5) during the first 5 days of
culture, but to 29F 3.6 Am during the next 5 days of culture.
Thus, on a population level, the cells showed an initial
phase of proliferation, and a second phase in which matu-
ration was predominant.
After thrombopoietin treatment of CD34+ cells, tran-
scription and surface expression of GPIIb-IIIa occur rela-
tively early during megakaryocytic differentiation, whereas
constituents of the GPIb-V–IX complex appear at later
differentiation stages [10]. Using flow cytometry, we com-
pared the surface expression levels of GPIIIa and GPIb on
individual cells during culture with thrombopoietin. Double-
staining of the cultured megakaryocytes with anti-GPIIIa–
FITC and anti-GPIba–PE gave two well separated cell
populations: cells expressing only GPIIIa at their surface,
and cells expressing both GPIIIa and GPIb (Fig. 1A). The
fraction of GPIIIa+/GPIb cells increased from 11F 5% to
37F 5% (meanF S.D., n = 3) during the first 5 days of
culture, while the fraction of GPIIIa+/GPIb+ cells increased
from 1F1% to 36F 4%. At this stage, about 50% of the
cells had lost CD34+ expression (see also Ref. [14]). More
prolonged culture for 10 days resulted in 87F 7% (n = 3)
GPIIIa+ cells, and 12F 3% GPIIIa+/GPIb and 76F 6%
GPIIIa+/GPIb+ cells, indicating that most of the cells in
population had differentiated along the megakaryocytic
lineage. The remaining GPIIIa/GPIb cells were identified
as either undifferentiated CD34+ cells or CD14+ cells of the
monocytic lineage. Co-staining for GPIIIa and GPIIb
showed that the GPIIIa+ cells also expressed GPIIb on their
surface, indicating that the a and h chains of integrin aIIbh3
were co-expressed on cultured megakaryocytes. A typical
finding was that essentially all cells that expressed GPIb
simultaneously expressed GPIIIa. The percentage of cells
that stained positively for GPIb but negatively for GPIIIa
was only 0.1–0.2%, which corresponds to the percentage of
Fig. 1. GPIIIa and GPIb surface expression patterns of cultured hematopoietic stem/progenitor cells. (A) Human CD34+ cells were cultured with
thrombopoietin for 1, 5 or 10 days. The cells were incubated with FITC- and PE-labeled negative control IgG (upper panels); other cells were incubated with
anti-GPIIIa–FITC and anti-GPIb–PE (lower panels). (B) CD34+ stem cells cultured for 10 days with thrombopoietin were stained with only anti-GPIIIa–
FITC (left panel), anti-GPIb–FITC (middle panel), or with anti-GPIb–FITC and propidium iodide (right panel). Dot plots of flow cytometric analyses are
given, representative for data obtained with cells from four different donors.
E. den Dekker et al. / Biochimica et Biophysica Acta 1643 (2003) 85–9488cells binding to the FITC/PE-labeled negative control anti-
bodies (0.2–0.3%) (Fig. 1A). Timely sequential expression
of GPIb after GPIIIa was confirmed on the mRNA level by
semi-quantitative RT-PCR (M. van Abel, 2001, unpublished
results). Together, this indicates that, during the megakar-
yocytic differentiation of CD34+ cells, early expression of
GPIIIa and late expression of GPIb are strictly sequential
events.
3.2. Nuclear polyploidy and actin cytoskeleton but not cell
size increase with expression of GPIb during
megakaryocytopoiesis
Because cell size mainly increases at later stages of
megakaryocytopoiesis, larger cells were expected to expresshigher levels of GPIIIa and GPIb. However, neither by flow
cytometry nor by immuno-cytology (see below) we could
establish a strict relation between cell size and glycoprotein
expression level. Forward-light scatter vs. sideward-light
scatter plots indicated that the cells in population increased
in average size, as expected (data not shown). However, dot
plot analysis of day-10 cells for forward-light scatter vs.
GPIIIa or GPIb staining also showed that, on a single-cell
level, there was no correlation between these parameters
(Fig. 1B). Thus, within the population smaller cells could be
identified with relatively high GPIIIa or GPIb staining and
vice versa.
Nuclear polyploidy is often used as a marker for mega-
karyocyte maturation and proplatelet formation. Flow cyto-
metric analysis of day-10 cells, using propidium iodide for
Fig. 2. GPIb expression and F-actin content of cultured hematopoietic stem/
progenitor cells. (A) Human CD34+ cells, cultured for 1, 5 or 10 days with
thrombopoietin, were fixed and stained with anti-GPIb–FITC and Texas
red-X-labeled phalloidin (F-actin staining). (A) Panels show confocal
images of FITC (left; GPIb) and Texas red-X (right; F-actin) fluorescence of
the same microscopic fields. Bar represents 10 Am. (B) Correlation plot of
FITC vs. Texas red-X fluorescence intensities (FI) from 61 different GPIb+
cells (R = 0.77, P= 0.001).
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showed that polyploid (>4N) cells were always positive for
GPIb (Fig. 1B, right panel). These data correspond with the
findings of Debili et al. [7], who also showed that the
appearance of GPIb on thrombopoietin-cultured cells corre-
lates with the onset of polyploidisation.
In platelets, GPIb is known to be associated with the
actin membrane skeleton [18]. The platelet actin cytoskel-
eton plays an important role in regulating the adhesive
function of the GPIb/V/IX complex, as inhibition of actin
polymerization enhances platelet aggregation induced by
vWF. To investigate the relation of actin content and GPIb
expression, CD34+ cells that were cultured for 1, 5 or 10
days with thrombopoietin were subjected to immunocytol-
ogy and stained for both F-actin (using Texas red X-labeled
phalloidin) and GPIb (using FITC-labeled F802 antibody).
As shown in Fig. 2A, the relatively small day-1 cells, which
mainly lacked expression of GPIb, had a low F-actin
content. Culturing for 5 days slightly increased the cell size
and induced GPIb expression. Interestingly, co-staining for
GPIb expression and F-actin content revealed that essential-
ly all GPIb+ cells were increased in F-actin in comparison to
GPIb cells. The increase in F-actin content during matu-
ration of megakaryocytes was even more apparent after 10
days of culture, when the majority of the cells expressed
GPIb. This was true for ‘resting’ cells with a peripheral
location of F-actin, but also for the few spread cells with
actin F-stress fibers (see Fig. 2A, day 10). When the
fluorescence intensities of GPIb and F-actin staining per
cell were compared, a highly significant correlation
(R = 0.77, P= 0.001) was obtained between both parameters
(Fig. 2B). There was, however, no obvious relation between
cell size and staining for GPIb or F-actin. As an example,
Fig. 2A shows a picture of two day-5 cells that are relatively
small in size but highly express GPIb as well as F-actin.
Apparently, the cytoskeletal F-actin content is more closely
linked to GPIb surface expression than to cell size.
3.3. Development of Gq-mediated Ca
2+ signaling occurs
independently of GPIb expression
In previous studies we have demonstrated that culturing
of CD34+ cells with thrombopoietin on a molecular level
increases the expression of heterotrimeric G proteins like Gq
and, in parallel, stimulates the Ca2 + responses elicited by Gq
protein-coupled receptors for thrombin (PAR1/4) and
thromboxane A2 (TPa) [11,12]. We determined how these
maturation-dependent changes in signaling related to the
sequential expression of GPIIIa and GPIb.
CD34+ cells cultured for 1 day with thrombopoietin were
adhered to coverslips coated with anti-CD34 antibody. Cells
cultured for 5 and 10 days were adhered to anti-GPIIIa
antibody-coated coverslips. Calcium responses were then
measured in individual adherent, Fura-2-loaded cells by
vital fluorescence imaging microscopy, after which cells
were stained with anti-GPIb antibody—and where appro-priate with anti-GPIIIa antibody—to distinguish between
immature GPIIIa+/GPIb and mature GPIIIa+/GPIb+ cells.
Of the day-1 progenitor cells, adhering to anti-CD34-coated
surface, hardly any cell stained positively for GPIb. The
percentage of more mature GPIb+ cells adhering to anti-
GPIIIa surface increased from 55% on day 5 to 68% on day
10. This again points to an increase in GPIb+ cells among
the GPIIIa+ cell population, as described above (compare
Fig. 1). The fraction of cells responding to the thromboxane
A2 analogue U46619 with a rise in [Ca
2 +]i gradually
increased during culture. On day 1, 9% of the stem cells
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of the GPIIIa+/GPIb cells on day 5 and to 32% for day 10
GPIIIa+/GPIb cells (Table 1). The percentage of U46619-
responsive GPIIIa+/GPIb+ cells showed even a sharper
increase going from 42% on day 5 to 67% on day 10.
Responsiveness to thrombin was already high on day 1
(82%) and remained almost the same during maturation to
GPIIIa+/GPIb+ cells (Table 1). Independent of the culturing
time, a lower fraction of the GPIIIa+/GPIb cells (64–68%)
compared with GPIIIa+/GPIb+ cells (82–89%) responded to
thrombin. Thus, many but typically not all mature cells,
expressing GPIIIa and GPIb, had gained the capability to
respond to thromboxane A2 and thrombin. In contrast, a
large majority of cells (97–100%), irrespective of their age
and glycoprotein expression pattern, showed a clear Ca2 +
response after stimulation with the sarco/endoplasmic-retic-
ulum Ca2 +-ATPase inhibitor thapsigargin (Table 1), indi-
cating that intracellular Ca2 + pumps are already functionally
active at an early stage of maturation.
In a set of experiments, the Fura-2-loaded cells were first
stimulated with U46619 and then with thrombin to deter-
mine how the responses to these agonists were linked.
Regardless of the culture time or GPIb expression, part of
the thrombin-responsive GPIIIa+ cells did not respond to
U46619 (55%, 48/88 cells), whereas almost all cells
responding to U46619 also gave a Ca2 + signal with throm-
bin (98%, 47/48 cells). These observations suggest that the
thromboxane-induced Ca2 + signaling arises later in the
differentiation than thrombin-induced signaling. It is thus
tempting to infer that the gain of responsiveness towards
U46619 progressively increases with megakaryocyte matu-
ration, along with the expression of GPIb. However, this
appeared not to be the case. For instance, among the day-5
cell population, cells that were responding to both U46619
and thrombin and U46619 were identified as either GPIIIa+/
GPIb+ or GPIIIa+/GPIb cells (Fig. 3A). Within the same
population, also GPIIIa+/GPIb+ cells were detected which
responded to thrombin but not to U46619. Similar differ-
ences were found for the longer cultured day-10 megakar-
yocytes. In the experiment of Fig. 3B, cell 1 and cell 2
hardly stained for GPIb, although cell 2 showed a signifi-Table 1
Fractions of cultured stem/progenitor cells responding to different Ca2 +-mobilizin
Day U46619 Thrombin
GPIb GPIb+ GPIb GPIb+
1 9% (53) –* 82% (76) –
5 26% (27) 42% (57) 68% (44) 82% (65)
10 32% (22) 67% (27) 64% (44) 89% (239)
Hematopoietic, day-1 cells were immobilised on coverslips coated with anti-C
immobilised on coverslips coated with anti-GPIIIa antibody. After loading with F
thapsigargin (2.5 AM), or iloprost (1 AM), in HEPES buffer containing 1 mM C
microscopic video imaging, after which the cells were stained with fluorescent anti
Given are percentages of cells responding to a particular agonist with an increase i
are derived from three to seven independent experiments.
* < 10 cells examined.cant, although small, Ca2 + response with U46619. Cell 3
with high GPIb expression level gave an (atypical) high
Ca2 + response with U46619 but only a moderate response
with thrombin, while cell 4 with lower GPIb expression
showed high responses with both U46619 and thrombin
(Fig. 3B). Thus, regardless of the general tendency of an
increase in Ca2 + signaling induced by U46619 and throm-
bin during megakaryocytopoiesis, many individual cells
deviated from the mainstream differentiation pattern in
various ways: responsiveness to U46619 could precede
the expression of GPIb+, responsiveness to U46619 could
remain absent after GPIb+ expression, or high responsive-
ness to U46619 was not accompanied by high responsive-
ness to thrombin. Taken together, this indicates that the
development of Ca2 + signaling with these Gq-activating
agonists occurs basically independently of the expression
of GPIb.
3.4. Down-regulation of Gs-mediated Ca
2+ signaling occurs
independently of GPIb expression
Stem/progenitor cells and immature megakaryocytes re-
spond to IP receptor stimulation by prostacyclin with a Gs-
mediated increase in cAMP level and a subsequent phospho-
lipase C-independent Ca2 + signal [14]. This Ca2 + response is
also induced by the prostacyclin derivative iloprost and the
adenylate cyclase activating agent, forskolin. It becomes lost
in mature megakaryocytes where, like in platelets, elevated
cAMP down-regulates the Ca2 + signal [14,19]. In individual
CD34+ cells cultured with thrombopoietin, we determined
the responsiveness to iloprost. As indicated in Table 1, the
percentage of cells showing a rise in [Ca2 +]i with iloprost was
26% for day-1 cells. This percentage only moderately de-
creased to 15–19% after 10 days of culture with thrombo-
poietin. When comparing the GPIb+ and GPIb cells, there
were only slightly higher percentages of iloprost-responsive
cells in the (immature) GPIIIa+/GPIb population of cells
(Table 1). Thus, although the Ca2 +-responsiveness towards
iloprost decreased during megakaryocytopoiesis, a signifi-
cant fraction of the GPIIIa+/GPIb+ cells kept this property. In
addition, we compared the iloprost- and thrombin-inducedg agonists
Thapsigargin Iloprost
GPIb GPIb+ GPIb GPIb+
98% (61) – 26% (47) –
100% (70) 98% (101) 33% (63) 27% (54)
97% (84) 100% (104) 19% (32) 15% (54)
D34 antibody; cells cultured for 5 or 10 days with thrombopoietin were
ura-2, the cells were stimulated with U46619 (1 AM), a-thrombin (10 nM),
aCl2. Calcium responses were recorded in individual cells by fluorescence
-GPIb (or anti-GPIIIa) antibody to identify the GPIb+ megakaryocytic cells.
n [Ca2 +]i; total number of analysed cells is indicated between brackets. Data
Fig. 3. Calcium responses of single hematopoietic stem/progenitor cells, cultured with thrombopoietin for 5 or 10 days. Cells were immobilised on a surface
covered with anti-GPIIIa antibody and loaded with Fura-2. Calcium responses in single cells were recorded by microscopic fluorescence imaging, after which
the cells were stained with anti-GPIb–FITC to identify GPIb+ cells. (A) Day-5 cells were stimulated with U46619 (1 AM) and thrombin (10 nM). Calcium
responses are given from 3 cells in one experiment. (B) Day-10 cells were stimulated with U46619 (1 AM) and thrombin (10 nM). Upper panel: FITC images
(GPIb expression), and Fura-2 ratio images before agonists, and after addition of U46619 and thrombin. Lower panel: Calcium responses of cells numbered 1–
4. (C) Day-5 cells were incubated with iloprost (1 AM) and thrombin (10 nM). Representative traces are given of 3 cells in one experiment.
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cells (Fig. 3C). It appeared that, regardless of the responsive-
ness towards thrombin, some of the GPIIIa+/GPIb cells did
not respond to iloprost, while some of the GPIIIa+/GPIb+
cells had retained their response to iloprost. Apparently, the
maturation-dependent disappearance of the Gs-mediated
Ca2 + signal can be completed in some cells before the start
of GPIb expression, while it continues in other cells after
GPIb expression. These results clearly show that the loss of
responsiveness for iloprost does not follow the strict timely
regulated pattern observed for GPIb expression.4. Discussion
Culturing of hematopoietic stem/progenitor cells in vitro
with thrombopoietin induces differentiation into immature
and mature megakaryocytes and proplatelets [9,20]. The
differentiating cells gradually acquire platelet characteristics,
with respect to expression of surface glycoproteins [10], G
proteins [12], cAMP-dependent protein kinase subunits [14],and signaling properties [13,21]. A usual premise is that the
differentiation process from progenitor cells to mature meg-
akaryocytes with platelet-like activation properties is marked
by a timely and sequential acquirement of constituents and
functions. Thus, a feasible way to track to which point of
megakaryocytopoiesis a stem cell has developed after cul-
turing with thrombopoietin would be determining the ‘plate-
let characteristics’ of that particular cell.
To study the differentiation process of megakaryocytes
and the development of platelet properties more thoroughly,
we performed sets of single-cell multi-parameter measure-
ments with CD34+ progenitor cells, directed to differentiate
along the megakaryocytic lineage by prolonged culturing
with thrombopoietin. Goal thereby was to compare various
differentiation characteristics on a single-cell base. We have
accorded and extended the results from others [7,10] that
consistent markers of maturation are surface expression of
GPIIIa, the h3 chain of the integrin aIIbh3 (fibrinogen
receptor), and later expression of GPIb, part of the GPIb/
V/IX vWF receptor complex. Particularly, we found that
hardly any cell that expressed GPIb was negative in GPIIIa
Fig. 4. Variable routes of maturation in CD34+ cells differentiating into
megakaryocytes. Essentially all differentiating megakaryocytes pass the
maturation stages of down-regulation (shown in italic) of CD34, followed
by expression of successively GPIIb-IIIa and GPIb-V–IX. However, the
maturing cells greatly differ in the time of development of Ca2 + signaling
properties. Whereas all cells of the population already show Ca2 + responses
to thrombin at an early stage, some cells gain Ca2 + responsiveness to
thromboxane A2 (TxA2) before GPIb expression, while other cells start to
respond only after GPIb expression. Similarly, the ability to respond to
prostacyclin by a Ca2 + signal becomes lost early in some cells, but later in
other cells.
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tially all cells lags behind that of GPIIIa. Apparently, surface
GPIIIa (integrin aIIbh3) expression is timely linked to that of
GPIb (vWF receptor complex), probably by strictly sched-
uled programming upon differentiation. It is described in the
literature that integrin aIIbh3 fulfils already a function in
immature megakaryocytes, as it is important for fibrinogen
uptake in a-granules [22], and is implicated in platelet
formation during the final stage of megakaryocytopoiesis
[23].
When comparing GPIb expression with other traditional
markers of megakaryocyte maturation, such as cell size
and polyploidy, only polyploidy appeared to be linked to
GPIb expression. This suggests that polyploidisation and
GPIb expression are co-regulated processes during mega-
karyocytopoiesis. The GPIb/V/IX receptor determines size
of shedding platelets, as absence of the complex results in
giant platelets. In platelets, GPIb is known to be linked to
the actin cytoskeleton, and this interaction mediates the
adhesive function of GPIb/V/IX [15]. In addition, GPIb/V/
IX interaction with vWF induces platelet shape change via
cytoskeleton reorganization [24]. We observed that during
megakaryocyte culture, the expression of GPIb strongly
correlates with staining for F-actin. Accordingly, at the
time point where GPIb becomes expressed, also intimate
interaction with the cytoskeleton might be built up. Thus,
the amount of F-actin can be considered as an indicator
reflecting the maturation stage of thrombopoietin-cultured
megakaryocytes. These data are in good agreement with
those presented for human megakaryocytes freshly isolated
from bone marrow aspirations [25]. Here, per cell both F-
actin and G-actin have also been found to increase with the
degree of megakaryocytic polyploidisation. However, the
authors also noted that the actin content decreased, when
expressed per diploid equivalent in the polyploid cells. In
other words, whereas the absolute content of actin
increases with maturation, this increase is insufficient to
follow the exponential increase in DNA content upon
polyploidisation.
We and others have previously described that—in pop-
ulations of cells—Ca2 + signaling by the platelet activators
thrombin, platelet-activating factor, ADP, thromboxane A2
and collagen increases during megakaryocyte maturation in
vitro, whereas Ca2 + signaling by prostacyclin is down-
regulated during megakaryocytopoiesis [12,21]. We
addressed the question whether also in individual cells the
up-regulation of platelet-signalling properties and the down-
regulation of non-platelet properties are strictly correlated
with glycoprotein expression. Also in the present study, we
observed clear trends in the groups of GPIIIa+/GPIb and
GPIIIa+/GPIb+ cells during culturing, i.e. increased Ca2 +
signal generation towards Gq-activating thrombin and
thromboxane receptor agonists, and decreased reactivity to
prostacyclin receptor agonists. More detailed examinations
indicated that all cells, even day-1 cells, had the capacity of
Ca2 + signal generation, as deduced from their universalresponse to thapsigargin, which was independent of GPIIIa
or GPIb expression pattern. While most but not all cells
(64–89%) responded to thrombin, essentially all thrombin-
responsive cells also show a Ca2 + signal with thromboxane
A2 receptor agonist. This points to a timely linked, sequen-
tial regulation of first, thrombin, and second, thromboxane
A2 responsiveness during differentiation. On the other hand,
the correlation between GPIb expression and thromboxane
A2 signaling was far from absolute. It appeared that a
significant fraction of the more mature GPIIIa+/GPIb+
megakaryocytes failed to respond to thromboxane A2,
whereas, conversely, some of the immature GPIIIa+/GPIb
megakaryocytes did show a response to thromboxane A2.
Therefore, in contrast to the sequential expression of GPIIIa
and GPIb, the gain of responsiveness towards thromboxane
is not strictly co-regulated with the expression of GPIb.
Earlier, we have shown that Gqa, which is the signaling G-
protein subunit involved in thromboxane- and thrombin-
evoked Ca2 + signal generation [26], is up-regulated during
megakaryocytopoiesis [12]. However, this mere up-regula-
tion is unlikely to explain the observed differences between
individual (im)mature megakaryocytes. For instance, Fig. 3
shows that particular cells have relatively high Ca2 +
responses to thromboxane analogue but not to thrombin,
while other cells respond better to thrombin. This clearly
suggests that other factors contribute to the intercellular
differences in responsiveness such as different rates of
receptor expression.
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induced, Gs-mediated Ca
2 + signaling. An appreciable frac-
tion of immature GPIIIa+/GPIb megakaryocytes did not
respond to iloprost, whereas a significant part of the GPIIIa+/
GPIb+ cells had kept this response. Thus, in single cells, the
disappearance of the iloprost signal can be completed either
before or after the onset of GPIb expression.
Together, the present single-cell analyses indicate that
megakaryocyte differentiation is not a uniquely single-
stream committed process that proceeds similarly in all
maturing cells. Instead, we can distinguish at least two,
but probably more, routes of developmental processes
which can proceed in different cells of a population at
different rates. This concept is schematically shown in
Fig. 4. Further research will need to unravel the (transcrip-
tion) factors responsible for this asynchronous differentia-
tion in individual cells.Acknowledgements
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